Follow
Alexandre Alanio
Alexandre Alanio
Associate Professor, Hôpital Saint Louis, University Paris Diderot, Institut Pasteur, Paris, France
Verified email at pasteur.fr - Homepage
Title
Cited by
Cited by
Year
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group …
OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ...
The Lancet infectious diseases 19 (12), e405-e421, 2019
13862019
Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19
A Alanio, S Dellière, S Fodil, S Bretagne, B Mégarbane
The Lancet Respiratory Medicine 8 (6), e48-e49, 2020
4382020
Real-Time Identification of Bacteria and Candida Species in Positive Blood Culture Broths by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass …
A Ferroni, S Suarez, JL Beretti, B Dauphin, E Bille, J Meyer, ME Bougnoux, ...
Journal of clinical microbiology 48 (5), 1542-1548, 2010
3412010
ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients
J Maertens, S Cesaro, G Maschmeyer, H Einsele, JP Donnelly, A Alanio, ...
Journal of Antimicrobial Chemotherapy 71 (9), 2397-2404, 2016
2702016
ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients
A Alanio, PM Hauser, K Lagrou, WJG Melchers, J Helweg-Larsen, ...
Journal of Antimicrobial Chemotherapy 71 (9), 2386-2396, 2016
2422016
Tracing the evolutionary history and global expansion of Candida auris using population genomic analyses
NA Chow, JF Muñoz, L Gade, EL Berkow, X Li, RM Welsh, K Forsberg, ...
MBio 11 (2), 10.1128/mbio. 03364-19, 2020
2352020
Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients
A Alanio, G Desoubeaux, C Sarfati, S Hamane, A Bergeron, E Azoulay, ...
Clinical microbiology and infection 17 (10), 1531-1537, 2011
2262011
Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of …
L Millon, R Herbrecht, F Grenouillet, F Morio, A Alanio, V Letscher-Bru, ...
Clinical Microbiology and Infection 22 (9), 810. e1-810. e8, 2016
2212016
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study
JP Gangneux, E Dannaoui, A Fekkar, CE Luyt, F Botterel, N De Prost, ...
The Lancet Respiratory Medicine 10 (2), 180-190, 2022
2032022
Matrix‐assisted laser desorption ionization time‐of‐flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species
A Alanio, JL Beretti, B Dauphin, E Mellado, G Quesne, C Lacroix, A Amara, ...
Clinical Microbiology and Infection 17 (5), 750-755, 2011
1972011
Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia
HJF Salzer, G Schäfer, M Hoenigl, G Günther, C Hoffmann, B Kalsdorf, ...
Respiration 96 (1), 52-65, 2018
1822018
MALDI‐TOF MS‐based drug susceptibility testing of pathogens: The example of Candida albicans and fluconazole
C Marinach, A Alanio, M Palous, S Kwasek, A Fekkar, JY Brossas, S Brun, ...
Proteomics 9 (20), 4627-4631, 2009
1802009
Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort
S Dellière, E Dudoignon, S Fodil, S Voicu, M Collet, PA Oillic, M Salmona, ...
Clinical Microbiology and Infection 27 (5), 790. e1-790. e5, 2021
1532021
Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies
A Alanio, E Sitterlé, M Liance, C Farrugia, F Foulet, F Botterel, Y Hicheri, ...
Journal of antimicrobial chemotherapy 66 (2), 371-374, 2011
1362011
Dynamics of Cryptococcus neoformans-macrophage interactions reveal that fungal background influences outcome during cryptococcal meningoencephalitis in humans
A Alanio, M Desnos-Ollivier, F Dromer
MBio 2 (4), 10.1128/mbio. 00158-11, 2011
1212011
Titan cells formation in Cryptococcus neoformans is finely tuned by environmental conditions and modulated by positive and negative genetic regulators
B Hommel, L Mukaremera, RJB Cordero, C Coelho, CA Desjardins, ...
PLoS pathogens 14 (5), e1006982, 2018
1132018
Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients
C Cordonnier, S Cesaro, G Maschmeyer, H Einsele, JP Donnelly, ...
Journal of Antimicrobial Chemotherapy 71 (9), 2379-2385, 2016
1112016
Tracing Genetic Exchange and Biogeography of Cryptococcus neoformans var. grubii at the Global Population Level
J Rhodes, CA Desjardins, SM Sykes, MA Beale, M Vanhove, ...
Genetics 207 (1), 327-346, 2017
992017
Cryptococcus neoformans host adaptation: toward biological evidence of dormancy
A Alanio, F Vernel-Pauillac, A Sturny-Leclère, F Dromer
MBio 6 (2), 10.1128/mbio. 02580-14, 2015
982015
Detection of circulating Mucorales DNA in critically ill burn patients: preliminary report of a screening strategy for early diagnosis and treatment
M Legrand, M Gits-Muselli, L Boutin, D Garcia-Hermoso, V Maurel, ...
Clinical Infectious Diseases 63 (10), 1312-1317, 2016
962016
The system can't perform the operation now. Try again later.
Articles 1–20